Ultragenyx Pharmaceutical Inc (RARE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Ultragenyx Pharmaceutical Inc Azioni (RARE) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	57.35% 214.00	136.00	207.28	159.93	166.50
Selling, General, and Administrative	0.00% 88.00	88.00	-	-	-
Operating Income/Loss	55.62% -75.00	-169.00	-113.28	-170.89	-107.89
Income/Loss From Continuing Operations Before Tax	50.54% -91.00	-184.00	-127.69	-179.54	-114.00
Income Tax Expense/Benefit	0.00% 1.00	1.00	0.87	0.873	0.947
Net Income/Loss	50.27% -92.00	-185.00	-128.56	-180.41	-114.95
Basic Average Shares	1.29% 101.90	100.60	0.4136	99.77	98.46
Diluted Average Shares	1.29% 101.90	100.60	0.4136	99.77	98.46
Basic Earnings Per Share	51.09% -0.90	-1.84	-1.28	-1.81	-1.17
Diluted Earnings Per Share	51.09% -0.90	-1.84	-1.28	-1.81	-1.17

NVAX

$10.32

2.99%

STOK

$26.41

1.07%

IMCR

$32.61

2.03%

NBTX

$33.98

1.59%

QURE

$24.97

2.84%

MESO

$13.39

1.59%